Estimates Revisions hVIVO plc OTC Markets
Stocks
OPORF
GB00B9275X97
Biotechnology & Medical Research
|
Market Closed -
OTC Markets
10:53:40 2026-06-12 EDT
|
5-day change | 1st Jan Change | ||
| 0.1096 USD | +27.29% |
|
-.--% | -54.33% |
| 10-01 | HVIVO plc Announces Termination of Stephen Mark Pinkerton as Director, Effective September 30, 2026 | CI |
| 09-23 | HVIVO plc, H1 2026 Earnings Call, Sep 15, 2026 |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
hVIVO plc(VENN)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
hVIVO plc(VENN)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
hVIVO plc(VENN)
EBIT
Dividend / Share (DPS)
Data source:
hVIVO plc(VENN)
Cash or Net Debt
- Stock Market
- Stocks
- VENN Stock
- OPORF Stock
- Consensus hVIVO plc
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
